Bayesian Hierarchical Varying-Sparsity Regression Models with Application to Cancer Proteogenomics

References

• Akbani, R., Ng, P. K. S., Werner, H. M., Shahmoradgoli, M., Zhang, F., Ju, Z., Liu, W., Yang, J.-Y., Yoshihara, K., Li, J. et al. (2014), “A Pan-Cancer Proteomic Perspective on the Cancer Genome Atlas,” Nature Communications, 5, 1–14.
   Web of Science ®Google Scholar
• Alfaro, J. A., Sinha, A., Kislinger, T., and Boutros, P. C. (2014), “Onco-Proteogenomics: Cancer Proteomics Joins Forces with Genomics,” Nature methods, 11, 1107–1113.
   PubMed Web of Science ®Google Scholar
• Anvekar, R. A., Asciolla, J. J., Missert, D. J., and Chipuk, J. E. (2011), “Born to be Alive: A Role for the BCL-2 Family in Melanoma Tumor Cell Survival, Apoptosis, and Treatment,” Frontiers in Oncology, 1, 1–14.
   PubMedGoogle Scholar
• Banumathy, G., and Cairns, P. (2010), “Signaling Pathways in Renal Cell Carcinoma,” Cancer Biology & Therapy, 10, 658–664.
   PubMed Web of Science ®Google Scholar
• Barbieri, M. M., and Berger, J. O. (2004), “Optimal Predictive Model Selection,” The Annals of Statistics, 32, 870–897.
   Web of Science ®Google Scholar
• Cantley, L. C., and Neel, B. G. (1999), “New Insights Into Tumor Suppression: PTEN Suppresses Tumor Formation by Restraining the Phosphoinositide 3-Kinase/AKT Pathway,” Proceedings of the National Academy of Sciences, 96, 4240–4245.
   PubMed Web of Science ®Google Scholar
• Chang, W., Cheng, J., Allaire, J., Xie, Y., and McPherson, J. (2015), Shiny: Web Application Framework for R. R package version 0.12.2.
   Google Scholar
• Chen, M., and Manley, J. L. (2009), “Mechanisms of Alternative Splicing Regulation: Insights from Molecular and Genomics Approaches,” Nature reviews Molecular Cell Biology, 10, 741–754.
   PubMed Web of Science ®Google Scholar
• Chintakuntlawar, A. V., Okuno, S. H., and Price, K. A. (2016), “Systemic Therapy for Recurrent or Metastatic Salivary Gland Malignancies,” Cancers of the Head & Neck, 1, 11.
   PubMedGoogle Scholar
• Church, G. M. (2004), “Proteogenomic Mapping as a Complementary Method to Perform Genome Annotation,” Proteomics, 4, 59–77.
   PubMed Web of Science ®Google Scholar
• Dalin, M. G., Watson, P. A., Ho, A. L., and Morris, L. G. (2017), “Androgen Receptor Signaling in Salivary Gland Cancer,” Cancers, 9, 17.
   PubMed Web of Science ®Google Scholar
• Davies, M., Hennessy, B., and Mills, G. B. (2006), “Point Mutations of Protein Kinases and Individualised Cancer Therapy,” Expert Opinion on Pharmacotherapy, 7, 2243–2261.
   PubMed Web of Science ®Google Scholar
• De Bono, J., and Ashworth, A. (2010), “Translating Cancer Research into Targeted Therapeutics,” Nature, 467, 543–549.
   PubMed Web of Science ®Google Scholar
• Fan, J., Ma, Y., and Dai, W. (2014), “Nonparametric Independence Screening in Sparse Ultra-High-Dimensional Varying Coefficient Models,” Journal of the American Statistical Association, 109, 1270–1284.
   PubMed Web of Science ®Google Scholar
• Gygi, S. P., Rochon, Y., Franza, B. R., and Aebersold, R. (1999), “Correlation Between Protein and mRNA Abundance in Yeast,” Molecular and Cellular Biology, 19, 1720–1730.
   PubMed Web of Science ®Google Scholar
• Hartwell, L. H., Hopfield, J. J., Leibler, S., and Murray, A. W. (1999), “From Molecular to Modular Cell Biology,” Nature, 402, C47–C52.
   PubMed Web of Science ®Google Scholar
• Hastie, T., and Tibshirani, R. (1993), “Varying-Coefficient Models,” Journal of the Royal Statistical Society, Series B, 55, 757–796.
   Google Scholar
• Heppner, G. H., and Miller, B. E. (1983), “Tumor Heterogeneity: Biological Implications and Therapeutic Consequences,” Cancer and Metastasis Reviews, 2, 5–23.
   PubMed Web of Science ®Google Scholar
• Jacob, F., Goldstein, D. R., Fink, D., and Heinzelmann-Schwarz, V. (2009), “Proteogenomic Studies in Epithelial Ovarian Cancer: Established Knowledge and Future Needs,” Biomarkers in Medicine, 3, 743–756.
   PubMed Web of Science ®Google Scholar
• Kitano, H. (2002), “Computational Systems Biology,” Nature, 420, 206–210.
   PubMed Web of Science ®Google Scholar
• Lee, C. T., Genega, E. M., Hutchinson, B., Fearn, P. A., Kattan, M. W., Russo, P., and Reuter, V. E. (2003), “Conventional (Clear Cell) Renal Carcinoma Metastases have Greater BCL-2 Expression Than High-Risk Primary Tumors,” in Urologic Oncology: Seminars and Original Investigations, volume 21, Elsevier, pp. 179–184.
   PubMed Web of Science ®Google Scholar
• Lessene, G., Czabotar, P. E., and Colman, P. M. (2008), “BCL-2 Family Antagonists for Cancer Therapy,” Nature Reviews Drug Discovery, 7, 989–1000.
   PubMed Web of Science ®Google Scholar
• Li, B., and Dewey, C. N. (2011), “RSEM: Accurate Transcript Quantification from RNA-Seq Data with or without a Reference Genome,” BMC Bioinformatics, 12, 323.
   PubMed Web of Science ®Google Scholar
• Li, J., Lu, Y., Akbani, R., Ju, Z., Roebuck, P. L., Liu, W., Yang, J.-Y., Broom, B. M., Verhaak, R. G., Kane, D. W. et al (2013), “Tcpa: A Resource for Cancer Functional Proteomics Data,” Nature Methods, 10, 1046–1047.
   PubMed Web of Science ®Google Scholar
• Lim, Y. C., Kang, H. J., Kim, Y. S., and Choi, E. C. (2012), “All-Trans-Retinoic Acid Inhibits Growth of Head and Neck Cancer Stem Cells by Suppression of wnt/β-Catenin Pathway,” European Journal of Cancer, 48, 3310–3318.
   PubMed Web of Science ®Google Scholar
• Lin, F., Zhang, P. L., Yang, X. J., Prichard, J. W., Lun, M., and Brown, R. E. (2006), “Morphoproteomic and Molecular Concomitants of an Overexpressed and Activated Mtor Pathway in Renal Cell Carcinomas,” Annals of Clinical & Laboratory Science, 36, 283–293.
   PubMed Web of Science ®Google Scholar
• Locard-Paulet, M., Pible, O., de Peredo, A. G., Alpha-Bazin, B., Almunia, C., Burlet-Schiltz, O., and Armengaud, J. (2016), “Clinical Implications of Recent Advances in Proteogenomics,” Expert Review of Proteomics, (just-accepted).
   PubMed Web of Science ®Google Scholar
• Longo, D. L. (2012), “Tumor Heterogeneity and Personalized Medicine,” N Engl J Med, 366, 956–957.
   PubMed Web of Science ®Google Scholar
• Margulis, V., Lin, J., Yang, H., Wang, W., Wood, C. G., and Wu, X. (2008), “Genetic Susceptibility to Renal Cell Carcinoma: The Role of DNA Double-Strand Break Repair Pathway,” Cancer Epidemiology Biomarkers & Prevention, 17, 2366–2373.
   PubMed Web of Science ®Google Scholar
• McLendon, R., Friedman, A., Bigner, D., Van Meir, E. G., Brat, D. J., Mastrogianakis, G. M., Olson, J. J., Mikkelsen, T., Lehman, N., Aldape, K. et al (2008), “Comprehensive Genomic Characterization Defines Human Glioblastoma Genes and Core Pathways,” Nature, 455, 1061–1068.
   PubMed Web of Science ®Google Scholar
• Nagalakshmi, U., Waern, K., and Snyder, M. (2010), “RNA-Seq: A Method for Comprehensive Transcriptome Analysis,” Current Protocols in Molecular Biology, 89, 4–11.
   Google Scholar
• Nesvizhskii, A. I. (2014), “Proteogenomics: Concepts, Applications and Computational Strategies,” Nature Methods, 11, 1114–1125.
   PubMed Web of Science ®Google Scholar
• Omberg, L., Ellrott, K., Yuan, Y., Kandoth, C., Wong, C., Kellen, M. R., Friend, S. H., Stuart, J., Liang, H., and Margolin, A. A. (2013), “Enabling Transparent and Collaborative Computational Analysis of 12 Tumor Types within the Cancer Genome Atlas,” Nature Genetics, 45, 1121–1126.
   PubMed Web of Science ®Google Scholar
• Paweletz, C. P., Charboneau, L., Bichsel, V. E., Simone, N. L., Chen, T., Gillespie, J. W., Emmert-Buck, M. R., Roth, M. J., Petricoin, E., and Liotta, L. A. (2001), “Reverse Phase Protein Microarrays Which Capture Disease Progression Show Activation of Pro-survival Pathways at the Cancer Invasion Front,” Oncogene, 20, 1981–1989.
   PubMed Web of Science ®Google Scholar
• Pinto, N., Black, M., Patel, K., Yoo, J., Mymryk, J. S., Barrett, J. W., and Nichols, A. C. (2014), “Genomically Driven Precision Medicine to Improve Outcomes in Anaplastic Thyroid Cancer,” Journal of Oncology, 2014.
   PubMedGoogle Scholar
• Rades, D., Seibold, N., Schild, S., Gebhard, M., and Noack, F. (2013), “Androgen Receptor Expression,” Strahlentherapie und Onkologie, 189, 849–855.
   PubMed Web of Science ®Google Scholar
• Ruppert, D., Wand, M. P., and Carroll, R. J. (2003), Semiparametric Regression, Number 12, Cambridge, UK: Cambridge University Press.
   Google Scholar
• Scheipl, F., Fahrmeir, L., and Kneib, T. (2012), “Spike-and-Slab Priors for Function Selection in Structured Additive Regression Models,” Journal of the American Statistical Association, 107, 1518–1532.
   Web of Science ®Google Scholar
• Scott, J. G., and Berger, J. O. (2010), “Bayes and Empirical-Bayes Multiplicity Adjustment in the Variable-Selection Problem,” The Annals of Statistics, 38, 2587–2619.
   Web of Science ®Google Scholar
• Soper, M. S., Iganej, S., and Thompson, L. D. (2014), “Definitive Treatment of Androgen Receptor–Positive Salivary Duct Carcinoma with Androgen Deprivation Therapy and External Beam Radiotherapy,” Head & Neck, 36, E4–E7.
   PubMed Web of Science ®Google Scholar
• Squarize, C. H., Castilho, R. M., Abrahao, A. C., Molinolo, A., Lingen, M. W., and Gutkind, J. S. (2013), “PTEN Deficiency Contributes to the Development and Progression of Head and Neck Cancer,” Neoplasia, 15, 461–471.
   PubMed Web of Science ®Google Scholar
• TCGA (2012), “Comprehensive Genomic Characterization of Squamous Cell Lung Cancers,” Nature, 489, 519–525.
   PubMed Web of Science ®Google Scholar
• ——— (2013), “Comprehensive Molecular Characterization of Clear Cell Renal Cell Carcinoma,” Nature, 499, 43–49.
   PubMed Web of Science ®Google Scholar
• Thorstenson, Y. R., Roxas, A., Kroiss, R., Jenkins, M. A., Kristine, M. Y., Bachrich, T., Muhr, D., Wayne, T. L., Chu, G., Davis, R. W. et al (2003), “Contributions of ATM Mutations to Familial Breast and Ovarian Cancer,” Cancer Research, 63, 3325–3333.
   PubMed Web of Science ®Google Scholar
• Tibes, R., Qiu, Y., Lu, Y., Hennessy, B., Andreeff, M., Mills, G. B., and Kornblau, S. M. (2006), “Reverse Phase Protein Array: Validation of a Novel Proteomic Technology and Utility for Analysis of Primary Leukemia Specimens and Hematopoietic Stem Cells,” Molecular Cancer Therapeutics, 5, 2512–2521.
   PubMed Web of Science ®Google Scholar
• Wang, H., Zhang, P., Lin, C., Yu, Q., Wu, J., Wang, L., Cui, Y., Wang, K., Gao, Z., and Li, H. (2015), “Relevance and Therapeutic Possibility of PTEN-Long in Renal Cell Carcinoma,” PloS One, 10, e114250.
   PubMed Web of Science ®Google Scholar
• Wang, K., Singh, D., Zeng, Z., Coleman, S. J., Huang, Y., Savich, G. L., He, X., Mieczkowski, P., Grimm, S. A., Perou, C. M. et al (2010), “Mapsplice: Accurate Mapping of RNA-Seq Reads for Splice Junction Discovery,” Nucleic Acids Research, 38, e178–e178.
   PubMed Web of Science ®Google Scholar
• Wang, L., Li, H., and Huang, J. Z. (2008a), “Variable Selection in Nonparametric Varying-Coefficient Models for Analysis of Repeated Measurements,” Journal of the American Statistical Association, 103, 1556–1569.
   PubMed Web of Science ®Google Scholar
• Wang, S., Nan, B., Zhu, J., and Beer, D. G. (2008b), “Doubly Penalized Buckley–James Method for Survival Data with High-Dimensional Covariates,” Biometrics, 64, 132–140.
   PubMed Web of Science ®Google Scholar
• Wang, Z., Gerstein, M., and Snyder, M. (2009), “RNA-Seq: A Revolutionary Tool for Transcriptomics,” Nature Reviews Genetics, 10, 57–63.
   PubMed Web of Science ®Google Scholar
• Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., Stuart, J. M., Network, C. G. A. R. et al (2013), “The Cancer Genome Atlas Pan-Cancer Analysis Project,” Nature Genetics, 45, 1113–1120.
   PubMed Web of Science ®Google Scholar
• Yang, F., Zeng, Q., Yu, G., Li, S., and Wang, C.-Y. (2006), “Wnt/β-Catenin Signaling Inhibits Death Receptor-Mediated Apoptosis and Promotes Invasive Growth of hnscc,” Cellular Signalling, 18, 679–687.
   PubMed Web of Science ®Google Scholar
• Zhu, Y., Qiu, P., and Ji, Y. (2014), “TCGA-Assembler: Open-Source Software for Retrieving and Processing TCGA Data,” Nature Methods, 11, 599–600.
   PubMed Web of Science ®Google Scholar